Although the cell-autonomous function of NPC1 limits the application of non-autonomous therapeutics, such as enzyme replacement therapy (Vanier, 2010), the ability to control the disorder cell-autonomously by providing NPC1 function to specific cell or tissue types enables the identification of cells that are important for neurodegenerative disease progression and, potentially, for recovery. Here, NPC1 is linked to neurodegenerative disease.